AI to Transform Independent and Assisted Living With Addison Virtual Caregiver

February 27, 2025 5:40 PM

As the market demands excellence in resident care, Addison Care is revolutionizing independent and assisted living with its AI-powered virtual care solution. Offering unmatched support, safety, retention, and profitability, Addison Care empowers senior living communities to improve resident outcomes while reducing operational risks-at just $8 per day. In a landscape where nearly all residents manage multiple chronic conditions and 7-14...

Read more

Alpha Genesis Primate Research Center Celebrates Successful USDA Inspection

February 27, 2025 5:00 PM

Alpha Genesis Incorporated (AGI) proudly announces the successful completion of its recent inspection by the United States Department of Agriculture (USDA). This accomplishment underscores AGI's unwavering commitment to the highest standards of animal care, research excellence, and regulatory compliance.During the comprehensive USDA inspection, AGI demonstrated its adherence to all applicable federal regulations, affirming its status as a...

Read more

MedMira Announces Partnership with MediGroup Physician Services in the United States

February 27, 2025 4:30 PM

MedMira Inc. (MedMira) (TSXV:MIR) announced today its partnership with MediGroup, a leader in the US health care industry since 1999. This new partnership allows the Company to promote and sell its products to over 44,000 existing customers.MediGroup is the United States's largest group purchasing organisations for Physicians' Offices, Surgery Centers and Specialty Clinics. MediGroup focuses on providing over 250,000 Health care employees the...

Read more

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

February 27, 2025 4:05 PM

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) ("Amphastar" or the "Company") today reported results for the three months and full year ended December 31, 2024.Fourth quarter HighlightsNet revenues of $186.5 million for the fourth quarterGAAP net income of $38.0 million, or $0.74 per share, for the fourth quarterAdjusted non-GAAP net income of $47.2 million, or $0.92 per share, for the fourth quarterFull Year HighlightsNet revenues of $732.0...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Updates FAQ in Response to a High Volume of Shareholder Questions

February 27, 2025 3:37 PM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that it had updated its investor FAQ in response to continued shareholder interest in its $50M pro forma revenue guidance, expected Sportstech acquisition, concerns about market manipulation and its plans for bitcoin as a treasury asset.For more commentary, information and details of...

Read more

ABE Technology Provides Update on Ongoing Strategic Transaction

February 27, 2025 2:30 PM

ABE Technology (H.K.) Company Limited ("ABE Technology") confirms that it has been engaged in an extensive and ongoing corporate action involving a significant entity within the healthcare technology sector. Given the advanced stage of this process and in compliance with relevant disclosure obligations under Hong Kong market regulations, the Company is providing this update to ensure transparency with its shareholders. Over the past 12 months,...

Read more

1933 Industries Announces First Quarter 2025 Financial Report

February 27, 2025 12:40 PM

1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2025") for the three months ended October 31, 2024 and 2023. All amounts expressed are in Canadian dollars.The Company owns 91% of Alternative Medicine Association (AMA), the Company's cultivation and production subsidiary centred on the medical...

Read more

DirectTrust(R) Names Lisa Nelson as Chief Technical Officer

February 27, 2025 12:30 PM

DirectTrust®, a non-profit healthcare industry alliance focused on scaling trust in healthcare technology and data exchange through standards, accreditation, and other services, today announced the appointment of Lisa R. Nelson MS, MBA as Chief Technical Officer (CTO), effective April 1, 2025. Nelson, a highly respected medical informaticist and innovator, brings over 25 years of experience in advancing interoperability, patient-centered data...

Read more

World Staffing Summit Names Travel Nurses, Inc. as a Top Agency

February 27, 2025 11:30 AM

The fifth annual World Staffing Summit announced Travel Nurses, Inc. as a top staffing agency for 2025. Travel Nurses, Inc. (TNI) placed third out of hundreds of staffing firms.Additionally, Marissa Morgan, a lead recruitment specialist with TNI, was named the top recruiter for the awards ceremony. TNI's Chief Financial Officer, Michelle Davis, ranked third on the list of top staffing leaders to watch in 2025. The agency was represented in each...

Read more

Spreading Hope: How Teva Is Improving Access to Medicines Across the Globe

February 27, 2025 10:05 AM

In high-income countries, more than 80% of children diagnosed with cancer will survive. Yet in some low- and middle-income countries, this number tragically drops to 20%1.At a UN General Assembly meeting in 2018, Dr. David G. Poplack, Global HOPE founding director (now retired) discovered that Teva provides a significant portion of the medicines that treat pediatric cancer, which can help change this reality. That's when Teva's partnership with...

Read more

CenExel Supports Metsera, Inc. in Successful Phase II Trial of MET-097 for Obesity and Metabolic Diseases

February 27, 2025 9:30 AM

CenExel is pleased to announce its partnership with Metsera, Inc., a clinical-stage biopharmaceutical company dedicated to advancing treatments for obesity and metabolic diseases, in support of its recent Phase 2a and Phase 2b clinical trials of MET-097. MET-097 is an ultra-long-acting injectable, fully-biased GLP-1 receptor agonist designed to address the growing global challenge of obesity.Metsera has shared positive topline results from the...

Read more

The Perfumery Launches New Website: A Better Experience for Shopping High-Quality Essential Oils

February 27, 2025 9:00 AM

The Perfumery, a bulk fragrance supplier specializing in the highest quality essential oils, custom blends, and clean fragrances, is excited to announce the launch of its newly optimized website. The site offers an improved experience for all users, including a streamlined purchasing process that makes it easier than ever for businesses to source the various scent products they need.Key features of The Perfumery's new website include:Flexible...

Read more

Jaguar Health Adopts Limited Duration Stockholder Rights Plan to Ensure Stockholders Can Realize Long-Term Value

February 27, 2025 8:30 AM

Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan")."Jaguar, which, like many other biotechnology companies, continues to experience a significant and ongoing dislocation in the trading price of its common stock, has received an indication of interest to acquire the Company. Our Board intends the Rights...

Read more

Bionic Bloom Announces Groundbreaking Non-ABA Therapy Framework: Empowerment-Based Integrated Treatment (EBiT)

February 27, 2025 8:00 AM

ST. PETERSBURG, FL / ACCESS Newswire / February 27, 2025 / Bionic Bloom, the nation's leading integrative mental health and wellness collective, proudly announces the launch of Empowerment-Based Integrated Treatment (EBiT)-a pioneering, non-ABA therapeutic framework designed to support and celebrate neurodivergent individuals. Developed by Dr. Angela Fisher, EBiT represents a paradigm shift in neurodivergent care by prioritizing self-esteem,...

Read more

iZafe Group's Board Member Magnus Engman Purchases 200,000 Shares

February 27, 2025 7:25 AM

STOCKHOLM, SE / ACCESSWIRE / February 27, 2025 / iZafe Group (STO:IZAFE-B) iZafe Group's board member, Magnus Engman, acquired 200,000 B-shares in the company on February 26, at a total value of 52,459 SEK (0.262 SEK per share).The acquisition is a clear signal of Magnus long-term confidence in iZafe's strategy and future potential. His total holding now amounts to 200,000 B-shares."I see great potential in iZafe's continued development and want...

Read more

Interactive Strength Inc. (Nasdaq:TRNR) Quickly Receives Repeat Six-Figure CLMBR Order in Germany

February 27, 2025 7:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or "the Company"), maker of innovative specialty fitness equipment under the CLMBR and FORME brands, today announced that it secured a repeat six-figure order for CLMBR from its Germany distributor, following its the initial six-figure order that was fulfilled in the Fall of 2024.Trent Ward, Co-Founder and CEO of TRNR, said: "Germany is the largest US fitness market outside the US, and this repeat...

Read more

Sunzen Reports Strong Growth in Q2 FY2025 with 236.4% Surge in Profit Before Tax

February 27, 2025 6:30 AM

Sunzen Group Berhad ("Sunzen" or "the Group"), formerly known as Sunzen Biotech Berhad and an established player in Malaysia's health products, medical devices and services, and loan financing with a diversified portfolio, has posted a 236.4% quarter-on-quarter ("QoQ") surge in profit before tax ("PBT") for the second quarter ended 31 December 2024 ("Q2 FY2025"), underscoring the success of its strategic shift towards high-margin businesses.The...

Read more

DC Healthcare Reports RM55.76 Million in Revenue for FYE2024

February 27, 2025 5:20 AM

DC Healthcare Holdings Berhad ("DC Healthcare" or the "Group"), an aesthetic medical services provider specialising in the provision of non-invasive and minimally invasive procedures, today announced its financial results for the fourth quarter ended 31 December 2024 ("4Q FY2024"). The Group recorded a revenue of RM16.61 million for the quarter and RM55.76 million for the financial year ended 31 December 2024 ("FYE2024").For 4Q FY2024, revenue...

Read more

AlzeCure Publishes its Year-End Report for January - December 2024

February 27, 2025 2:30 AM

AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced that its Year-end report for the period January - December 2024 is now available on the company's website: www.alzecurepharma.com/en/section/investors/financial-reports/"The fourth quarter of 2024 was yet another positive and eventful quarter for AlzeCure Pharma. During the quarter, we published and presented new positive preclinical findings from our...

Read more

IRLAB Publishes Phase IIb Data on Mesdopetam in Movement Disorders Clinical Practice

February 27, 2025 1:20 AM

IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, February 27, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company that discovers and develops new treatments for Parkinson's disease, today announces that data from the company's Phase IIb study of mesdopetam has been published in Movement Disorders Clinical Practice. The publication in this prestigious, peer-reviewed medical journal further validates the integrity and...

Read more